Cardiovascular Diseases Research in Colorado
Cardiovascular Diseases Research (93.837) awarded $334 million to recipients in Colorado in 320 grants from fiscal 2021 to 2025, 2.3% of the program's national total. The Regents of the University of Colorado received the most, $225 million.
- Awarded in Colorado$334 million
- Awards320
- Share of the program2.3%
- Rank among states16th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 149 | $71.9 million |
| FY 2022 | 153 | $66.8 million |
| FY 2023 | 157 | $64.9 million |
| FY 2024 | 147 | $65.9 million |
| FY 2025 | 146 | $64.9 million |
Recipients in Colorado
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Regents of the University of Colorado | Colleges and universities | 203 | $225 million |
| National Jewish Health | Nonprofits | 49 | $64.6 million |
| The Regents of the University of Colorado | Colleges and universities | 24 | $16.2 million |
| Colorado State University | Colleges and universities | 15 | $12.8 million |
| University of Denver | Colleges and universities | 7 | $6.8 million |
| Denver Health and Hospital Authority | Other | 3 | $2.5 million |
| Lazzaro Medical, Inc. | Small businesses | 1 | $2.4 million |
| Prolocor Inc | Small businesses | 1 | $2.0 million |
| Vesicle Therapeutics Inc | Small businesses | 2 | $744,668 |
| Quspin Inc. | Small businesses | 1 | $497,890 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Colorado?
$334 million from fiscal 2021 to 2025, across 320 awards. Colorado ranks 16th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Colorado?
The largest recipient is The Regents of the University of Colorado, with $225 million in 203 awards. Next are National Jewish Health and The Regents of the University of Colorado.
Can organizations in Colorado apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Colorado
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Airport Improvement Program, Infrastructure Investment and Jobs Act Programs, and COVID-19 Airports Programs
- 1332 State Innovation Waivers
- Special Education Grants to States
- Federal Transit Formula Grants